Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Anheuser-Busch Gears Up for Super Bowl Ad Game
Benoit Garbe, chief marketing officer at Anheuser-Busch, joined Cheddar News to discuss Super Bowl ads and what lies ahead after the company ended an exclusive deal with the big game last year.
Load More